These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 9649454)
21. Overexpression of p53 protein in Barrett's syndrome with malignant transformation. Fléjou JF; Potet F; Muzeau F; Le Pelletier F; Fékété F; Hénin D J Clin Pathol; 1993 Apr; 46(4):330-3. PubMed ID: 8496390 [TBL] [Abstract][Full Text] [Related]
22. Persistence of Human Papillomavirus, Overexpression of p53, and Outcomes of Patients After Endoscopic Ablation of Barrett's Esophagus. Rajendra S; Wang B; Pavey D; Sharma P; Yang T; Lee CS; Gupta N; Ball MJ; Gill RS; Wu X Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1364-1368.e5. PubMed ID: 25460562 [TBL] [Abstract][Full Text] [Related]
23. p53 gene mutations in Barrett's epithelium and esophageal cancer. Casson AG; Mukhopadhyay T; Cleary KR; Ro JY; Levin B; Roth JA Cancer Res; 1991 Aug; 51(16):4495-9. PubMed ID: 1868473 [TBL] [Abstract][Full Text] [Related]
24. p53 expression in Barrett's oesophagus, dysplasia, and adenocarcinoma using antibody DO-7. Symmans PJ; Linehan JM; Brito MJ; Filipe MI J Pathol; 1994 Jul; 173(3):221-6. PubMed ID: 7931842 [TBL] [Abstract][Full Text] [Related]
25. Analysis of Ki-67, p53 and Bcl-2 expression in the dysplasia-carcinoma sequence of Barrett's esophagus. Rioux-Leclercq N; Turlin B; Sutherland F; Heresbach N; Launois B; Campion JP; Ramee MP Oncol Rep; 1999; 6(4):877-82. PubMed ID: 10373674 [TBL] [Abstract][Full Text] [Related]
26. Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma. Bani-Hani K; Martin IG; Hardie LJ; Mapstone N; Briggs JA; Forman D; Wild CP J Natl Cancer Inst; 2000 Aug; 92(16):1316-21. PubMed ID: 10944553 [TBL] [Abstract][Full Text] [Related]
27. Detection of p53 nuclear protein accumulation in brushings and biopsies of Barrett's esophagus. Tsai TT; Bongiorno PF; Orringer MB; Beer DG Cancer Detect Prev; 1997; 21(4):326-31. PubMed ID: 9232323 [TBL] [Abstract][Full Text] [Related]
28. The usefulness of chromoendoscopy with methylene blue in Barrett's metaplasia and early esophageal carcinoma. Ormeci N; Savas B; Coban S; Palabiyikoğlu M; Ensari A; Kuzu I; Kursun N Surg Endosc; 2008 Mar; 22(3):693-700. PubMed ID: 17704887 [TBL] [Abstract][Full Text] [Related]
30. High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins. Chatelain D; Fléjou JF Virchows Arch; 2003 Jan; 442(1):18-24. PubMed ID: 12536310 [TBL] [Abstract][Full Text] [Related]
31. Histopathologic evaluation of an animal model for Barrett's esophagus and adenocarcinoma of the distal esophagus. Buskens CJ; Hulscher JB; van Gulik TM; Ten Kate FJ; van Lanschot JJ J Surg Res; 2006 Oct; 135(2):337-44. PubMed ID: 16926029 [TBL] [Abstract][Full Text] [Related]
32. The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma. Brabender J; Marjoram P; Lord RV; Metzger R; Salonga D; Vallböhmer D; Schäfer H; Danenberg KD; Danenberg PV; Selaru FM; Baldus SE; Hölscher AH; Meltzer SJ; Schneider PM Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2113-7. PubMed ID: 16172218 [TBL] [Abstract][Full Text] [Related]
33. Adenocarcinoma arising in Barrett's oesophagus: evidence for the participation of p53 dysfunction in the dysplasia/carcinoma sequence. Hardwick RH; Shepherd NA; Moorghen M; Newcomb PV; Alderson D Gut; 1994 Jun; 35(6):764-8. PubMed ID: 8020801 [TBL] [Abstract][Full Text] [Related]
34. Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study. Bytzer P; Christensen PB; Damkier P; Vinding K; Seersholm N Am J Gastroenterol; 1999 Jan; 94(1):86-91. PubMed ID: 9934736 [TBL] [Abstract][Full Text] [Related]